List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 39 studies with search of: "Deferasirox"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
Condition: Hyperferremia
Intervention: Drug: deferasirox:
2 Recruiting Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both
Condition: Thalassemia
Interventions: Drug: Deferoxamine;   Drug: Deferasirox
3 Active, not recruiting Pilot Study for Patients With Poor Response to Deferasirox
Conditions: Transfusion-Dependent Hemachromatosis;   Thalassemia Major;   Sickle Cell Disease
Interventions: Drug: Deferoxamine;   Drug: Deferasirox;   Radiation: HIDA
4 Recruiting Efficacy and Safety of Deferasirox in Non-Transfusion Dependent Thalassemia Patients With Iron Overload
Condition: Thalassemia Intermedia Syndrome
Interventions: Drug: deferasirox;   Drug: deferasirox placebo
5 Recruiting Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Intervention: Drug: Deferasirox
6 Completed Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
Conditions: Myelodysplastic Syndrome;   Iron Overload
Intervention: Drug: Deferasirox
7 Active, not recruiting Extension Study on Efficacy and Safety of Deferasirox Treatment in Patients With Beta-Thalassemia and Transfusional Hemosiderosis
Condition: Beta-Thalassemia Major
Intervention: Drug: ICL670; deferasirox
8 Completed Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload
Condition: Transfusional Iron Overload
Intervention: Drug: Deferasirox
9 Recruiting Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-Dependent Iron Overload
Conditions: Myelodysplastic Syndromes;   Transfusion Dependent Iron Overload
Intervention: Drug: ICL670/Deferasirox
10 Recruiting Efficacy and Safety of Oral Deferasirox (20 mg/kg/Day) in Patients Three to Six Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
Condition: Iron Overload
Intervention: Drug: ICL670/Deferasirox
11 Recruiting ICL670 in Patients With Chronic Anemia and Transfusional Hemosiderosis
Conditions: Anemia;   Hemosiderosis
Intervention: Drug: Deferasirox (ICL670)
12 Active, not recruiting Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
Condition: Hereditary Hemochromatosis
Intervention: Drug: deferasirox
13 Recruiting Safety, Tolerability, and Efficacy of Deferasirox in MDS
Conditions: Myelodysplastic Syndromes;   Hemosiderosis
Intervention: Drug: Deferasirox
14 Active, not recruiting Cardiac T2* in Beta-Thalassemia Patients on Deferasirox Treatment
Conditions: Beta-Thalassemia;   Iron Overload
Intervention: Drug: Deferasirox
15 Completed Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Deferasirox;   Drug: Rifampicin
16 Recruiting The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study
Condition: Mucormycosis
Intervention: Drug: deferasirox
17 Recruiting Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload
Conditions: Transfusional Iron Overload in the Heart;   Transfusional Hemosiderosis
Interventions: Drug: Deferasirox;   Drug: Deferoxamine
18 Recruiting ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
Condition: Anemia
Intervention: Drug: Deferasirox
19 Active, not recruiting Efficacy and Safety of Deferasirox in Patients With Transfusion-Dependent Iron Overload
Condition: Transfusion-Dependent Iron Overload
Intervention: Drug: Deferasirox
20 Active, not recruiting An Extension Study of Iron Chelation Therapy With Deferasirox in β-Thalassemia Patients With Transfusional Iron Overload
Condition: Transfusional Iron Overload in β-Thalassemia
Intervention: Drug: Deferasirox

Previous Page Studies Shown (1-20) Next Page (21-39)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services